Cargando…

The impact of key monitoring policy on the usage of policy-related drugs in Hubei Province, China

Introduction: This study evaluated quantitatively the impact of the first batch of the catalog of Key Monitoring and Rational Use Drugs (KMRUD) in Hubei Province on policy-related drug use and expenditures. Methods: This study is aimed to provide a basis for the successful implementation of subseque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Xiaotong, Wang, Yue, Chen, Xiaoze, Liu, Yuxin, Mao, Zongfu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976703/ https://www.ncbi.nlm.nih.gov/pubmed/36874018 http://dx.doi.org/10.3389/fphar.2023.1088723

Ejemplares similares

The impacts of the “4+7” pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study
por: Wen, Xiaotong, et al.
Publicado: (2022)

Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls
por: Chen, Yilin, et al.
Publicado: (2021)

A quasi-experimental study of the volume-based procurement (VBP) effect on antiviral medications of hepatitis B virus in China
por: Wen, Xiaotong, et al.
Publicado: (2023)

The Impact of a National Stewardship Policy on the Usage Patterns of Key Monitoring Drugs in a Tertiary Teaching Hospital: An Interrupted Time Series Analysis
por: Li, Haiyan, et al.
Publicado: (2022)

The change of drug utilization in China’s public healthcare institutions under the “4 + 7” centralized drug procurement policy: Evidence from a natural experiment in China
por: Lu, Jiancheng, et al.
Publicado: (2022)

Changing Characteristics of Pharmaceutical Prices in China Under Centralized Procurement Policy: A Multi-Intervention Interrupted Time Series
por: Long, Hongfei, et al.
Publicado: (2022)

The Impact of China's Paired Assistance Policy on the COVID-19 Crisis—An Empirical Case Study of Hubei Province
por: Huang, Rui, et al.
Publicado: (2022)

Policy implementation of methadone maintenance treatment and HIV infection: evidence from Hubei province, China
por: Dai, Jifang, et al.
Publicado: (2013)

What Factors Hindered the Access to Essential Anticancer Medicine in Public Hospitals for the Local Population in Hubei Province, China
por: Chen, Chaoyi, et al.
Publicado: (2021)

Impact of ‘4+7’ volume-based drug procurement on the use of policy-related original and generic drugs: a natural experimental study in China
por: Wang, Jing, et al.
Publicado: (2022)

The Effects of City Lockdown Policy on Frozen Embryo Transfer Outcome during COVID-19 Epidemic in Hubei Province, China
por: Liao, Huiqi, et al.
Publicado: (2022)

The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China
por: Chen, Lei, et al.
Publicado: (2020)

Antibiotic Use in China’s Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018–2020
por: Yang, Ying, et al.
Publicado: (2022)

Does Having a Usual Primary Care Provider Reduce Polypharmacy Behaviors of Patients With Chronic Disease? A Retrospective Study in Hubei Province, China
por: Wang, Jia, et al.
Publicado: (2022)

The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018–2019: an interrupted time-series analysis
por: Yang, Ying, et al.
Publicado: (2021)

The Effects of a New Public Medicine Procurement Policy on Medicine Price in Shaanxi Province, Western China: An Interrupted Time Series Analysis
por: Hu, Shuchen, et al.
Publicado: (2019)

Hubei's Core Response Policies in the Early Stage of COVID-19
por: Zhang, Yuyao, et al.
Publicado: (2021)

Pathogenic Leptospira Infections in Hubei Province, Central China
por: Xu, Jiale, et al.
Publicado: (2022)

Characteristics of Diagnosed and Death Cases of Pneumoconiosis in Hubei Province, China, 1949–2019
por: Yao, Yuxin, et al.
Publicado: (2022)

Editorial: Women in drugs outcomes research and policies: 2021
por: Alves da Costa, Filipa, et al.
Publicado: (2022)

Situation, Impacts, and Future Challenges of Tobacco Control Policies for Youth: An Explorative Systematic Policy Review
por: Ranabhat, Chhabi Lal, et al.
Publicado: (2019)

Editorial: Rising stars in drugs outcomes research and policies: 2021
por: Lins, Robert L., et al.
Publicado: (2022)

Evaluation of Health Care System Reform in Hubei Province, China
por: Sang, Shuping, et al.
Publicado: (2014)

The availability, price and affordability of essential antibacterials in Hubei province, China
por: Wu, Guangjie, et al.
Publicado: (2018)

High-Resolution Data on Human Behavior for Effective COVID-19 Policy-Making — Wuhan City, Hubei Province, China, January 1–February 29, 2020
por: Wang, Jingyuan, et al.
Publicado: (2023)

Impact of the Low-Price Medicine Policy on Medicine Supply in China: An Interrupted Time-Series Analysis
por: Zhao, Mingyue, et al.
Publicado: (2021)

Vitisshizishanensis, a new species of the grape genus from Hubei province, China
por: Ma, Zhi-Yao, et al.
Publicado: (2021)

Development and validation of a scoring system for the prediction of HIV drug resistance in Hubei province, China
por: Yan, Jisong, et al.
Publicado: (2023)

Editorial: Emerging talents in pharmacology: Drugs outcomes research and policies 2022
por: Linger, Rachel M. A., et al.
Publicado: (2023)

Editorial: Pharmaceutical policy, impact and health outcomes
por: Kwon, Hye-Young, et al.
Publicado: (2023)

Effects of Volume-Price Contracts on Pharmaceutical Prices: A Retrospective Comparative Study of Public Hospitals in Hubei of China
por: Li, Zhuoxian, et al.
Publicado: (2021)

Quantitatively monitoring AIDS policy implementation in China
por: Liu, Yufen, et al.
Publicado: (2010)

Ehrlichia species in pond-farmed leeches (Hirudinaria sp.) in Hubei Province, China
por: Zhou, Shu-Han, et al.
Publicado: (2019)

Feasibility of containing shigellosis in Hubei Province, China: a modelling study
por: Rui, Jia, et al.
Publicado: (2020)

Genetic and Clinical Characteristics of Patients With Hereditary Spherocytosis in Hubei Province of China
por: Wang, Xiong, et al.
Publicado: (2020)

Epidemiological characteristics and transmissibility of shigellosis in Hubei Province, China, 2005 – 2017
por: Chen, Qi, et al.
Publicado: (2020)

MERS-related CoVs in hedgehogs from Hubei Province, China
por: Li, Dan, et al.
Publicado: (2021)

Tick virome diversity in Hubei Province, China, and the influence of host ecology
por: Xu, Lin, et al.
Publicado: (2021)

Research on Maternal Service Area and Referral System in Hubei Province, China
por: Bai, Lingyao, et al.
Publicado: (2022)

Toward an Improved Multi-Criteria Drug Harm Assessment Process and Evidence-Based Drug Policies
por: Dubljević, Veljko
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lrk692hqu9cfa9g6n4u2tinqjd